LOGO
LOGO

Intraday Alerts

Aurinia Pharma Falls More Than 25%; Downtick Continues

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Aurinia Pharmaceuticals Inc. (AUPH) shares are sliding more than 25 percent from the previous close, continuing a bearish trend in search of new support, after the company peaked to a five-year high by end of October. There were no corporate announcements on the day to impact the stock movement.

Currently, shares are at $21.38, down 25.27 percent from the previous close of $28.47 on a volume of 9,604,248. The shares have traded in a range of $9.72-$33.97 on average volume of 4,431,581.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - December 22 - 26, 2025

December 26, 2025 08:42 ET
Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.